G. Xu
Impact in
-
- Gastroesophageal reflux and treatments
- Gastrointestinal motility and disorders
-
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Papers in
- Oncology 4
-
- Immune Cell Function and Interaction 2
- T-cell and B-cell Immunology 1
- Co-authors
- Xiaobei Zhan (1 shared paper)Jun Gao (1 shared paper)Richard Wu (1 shared paper)Zhangdong Jin (1 shared paper)Yu Bai (1 shared paper)Yiqi Du (1 shared paper)Fei Liu (1 shared paper)Yongzhao Yao (1 shared paper)
- Journals
- International Journal of Oncology (1 paper)Frontiers in Oncology (1 paper)Journal of Molecular Histology (1 paper)Transplantation and Cellular Therapy (1 paper)Journal of Cellular and Molecular Medicine (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
G. Xu
10 papers receiving 104 citations
Peers
Comparison fields: 5 of 30
- Gastroenterology 14
- Hematology 14
- Transplantation 2
- Surgery 26
- Oncology 12
Countries citing papers authored by G. Xu
This map shows the geographic impact of G. Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Xu more than expected).
Fields of papers citing papers by G. Xu
This network shows the impact of papers produced by G. Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Xu. The network helps show where G. Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 60 | |
| 2 | 2018 | 14 | |
| 3 | 2020 | 7 | |
| 4 | 2022 | 6 | |
| 5 | [The immune effects of rituximab on dendritic cells derived from patients with primary immune thrombocytopenia]. | 2012 | 5 |
| 6 | 2022 | 3 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 3 | |
| 9 | 1995 | 2 | |
| 10 | 2024 | 1 |
About G. Xu
G. Xu is a scholar working on Oncology, Immunology, Public Health, Environmental and Occupational Health, Surgery and Hematology, having authored 10 papers that have together received 104 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (2 papers), Immune Cell Function and Interaction (2 papers), Acute Myeloid Leukemia Research (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Lymphoma Diagnosis and Treatment (1 paper), T-cell and B-cell Immunology (1 paper), Down syndrome and intellectual disability research (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). The work is most often cited by research in Gastroenterology (14 citations), Hematology (14 citations), Transplantation (2 citations), Surgery (26 citations) and Oncology (12 citations). G. Xu has collaborated with scholars based in China and United States. Frequent co-authors include Xiaobei Zhan, Jun Gao, Richard Wu, Zhangdong Jin, Yu Bai, Yiqi Du, Fei Liu, Yongzhao Yao, Wenjun Zhang and Meiyu Zhou. Their work appears in journals such as International Journal of Oncology, Frontiers in Oncology, Journal of Molecular Histology, Transplantation and Cellular Therapy and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.